FB
GSK icon

Fulton Bank’s GSK GSK Stock Holding History

Fulton Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,958
Closed -$274K – 704
2026
Q1 		$274K Sell
4,958
-37,946
-88% -$2.06M 0.01% 580
2025
Q4 		$2.1M Sell
42,904
-2,684
-6% -$125K 0.07% 177
2025
Q3 		$1.97M Sell
45,588
-1,398
-3% -$54.6K 0.07% 185
2025
Q2 		$1.8M Buy
+46,986
New +$1.8M 0.07% 203
2024
Q4 		– Sell
-9,576
Closed -$391K – 683
2024
Q3 		$391K Buy
+9,576
New +$392K 0.01% 482
2023
Q3 		– Sell
-10,150
Closed -$362K – 581
2023
Q2 		$362K Buy
10,150
+1,246
+14% +$44.7K 0.02% 401
2023
Q1 		$317K Buy
8,904
+2,048
+30% +$71.7K 0.02% 418
2022
Q4 		$241K Sell
6,856
-5,773
-46% -$192K 0.01% 459
2022
Q3 		$372K Buy
12,629
+2,623
+26% +$99.4K 0.02% 341
2022
Q2 		$544K Buy
10,006
+1,331
+15% +$73.5K 0.03% 290
2022
Q1 		$472K Sell
8,675
-1,348
-13% -$73.2K 0.02% 328
2021
Q4 		$552K Buy
+10,023
New +$521K 0.02% 323
2021
Q1 		– Sell
-7,770
Closed -$357K – 485
2020
Q4 		$357K Sell
7,770
-34,513
-82% -$1.59M 0.02% 320
2020
Q3 		$1.99M Sell
42,283
-3,167
-7% -$159K 0.12% 126
2020
Q2 		$2.32M Sell
45,450
-9,507
-17% -$488K 0.15% 108
2020
Q1 		$2.6M Sell
54,957
-3,912
-7% -$209K 0.21% 94
2019
Q4 		$3.46M Buy
58,869
+4,322
+8% +$240K 0.21% 88
2019
Q3 		$2.91M Buy
54,547
+29
+0.1% +$1.49K 0.2% 96
2019
Q2 		$2.73M Sell
54,518
-921
-2% -$46.2K 0.18% 104
2019
Q1 		$2.9M Buy
55,439
+318
+0.6% +$15.9K 0.2% 97
2018
Q4 		$2.62M Buy
55,121
+931
+2% +$45.8K 0.21% 97
2018
Q3 		$2.72M Buy
54,190
+384
+0.7% +$19.5K 0.18% 103
2018
Q2 		$2.71M Sell
53,806
-1,649
-3% -$83.1K 0.19% 99
2018
Q1 		$2.71M Sell
55,455
-1,995
-3% -$92.9K 0.19% 97
2017
Q4 		$2.55M Sell
57,450
-2,765
-5% -$128K 0.18% 102
2017
Q3 		$3.06M Buy
60,215
+2,812
+5% +$143K 0.23% 86
2017
Q2 		$3.09M Buy
57,403
+1,666
+3% +$88.8K 0.24% 82
2017
Q1 		$2.94M Sell
55,737
-3,733
-6% -$189K 0.24% 84
2016
Q4 		$2.86M Sell
59,470
-11,269
-16% -$557K 0.25% 82
2016
Q3 		$3.81M Sell
70,739
-6,088
-8% -$334K 0.35% 53
2016
Q2 		$4.16M Buy
76,827
+2,160
+3% +$114K 0.41% 51
2016
Q1 		$3.79M Buy
74,667
+5,020
+7% +$250K 0.38% 55
2015
Q4 		$3.51M Sell
69,647
-6,955
-9% -$355K 0.36% 59
2015
Q3 		$3.68M Buy
76,602
+10,790
+16% +$562K 0.42% 54
2015
Q2 		$3.43M Buy
65,812
+1,186
+2% +$66.8K 0.36% 57
2015
Q1 		$3.73M Buy
64,626
+4,572
+8% +$262K 0.39% 47
2014
Q4 		$3.21M Buy
60,054
+8,533
+17% +$477K 0.36% 58
2014
Q3 		$2.96M Buy
51,521
+7,338
+17% +$450K 0.34% 63
2014
Q2 		$2.95M Buy
44,183
+10,046
+29% +$680K 0.33% 66
2014
Q1 		$2.28M Sell
34,137
-861
-2% -$58.2K 0.26% 74
2013
Q4 		$2.34M Sell
34,998
-10,984
-24% -$712K 0.27% 75
2013
Q3 		$2.88M Sell
45,982
-412
-0.9% -$26.5K 0.34% 70
2013
Q2 		$2.9M Buy
+46,394
New +$2.94M 0.36% 67

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Fulton Bank's GSK Position: Q2 2026 in Review

Fulton Bank sold out of GSK (GSK) in Q2 2026, closing a stake of 4,958 shares — an estimated $274K sold.

Fulton Bank first reported a position in GSK in Q2 2013 and held it in 43 quarters. The position peaked at $4.16M in Q2 2016. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Fulton Bank reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Fulton Bank sold 4,958 GSK shares in Q2 2026, an estimated $274K.
  • Fulton Bank first reported a position in GSK in Q2 2013 and held it in 43 quarters.
  • Fulton Bank's GSK position peaked at $4.16M in Q2 2016.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.